U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H4N4O6
Molecular Weight 252.1406
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FG-9041

SMILES

[O-][N+](=O)C1=CC2=C(NC(=O)C(=O)N2)C=C1[N+]([O-])=O

InChI

InChIKey=RWVIMCIPOAXUDG-UHFFFAOYSA-N
InChI=1S/C8H4N4O6/c13-7-8(14)10-4-2-6(12(17)18)5(11(15)16)1-3(4)9-7/h1-2H,(H,9,13)(H,10,14)

HIDE SMILES / InChI

Molecular Formula C8H4N4O6
Molecular Weight 252.1406
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

FG-9041 (6,7-Dinitroquinoxaline-2,3-dion or DNQX) is an antagonist of non-NMDA glutamate (AMPA and kainate) receptor. FG-9041 is used in molecular biology to identify the properties of different types of channels. In addition, experiments in rats have shown that DNQX reduces electroconvulsive shock-induced impairment of learning-memory.

Approval Year

Targets

Targets

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Diphenyl ditelluride induces hypophosphorylation of intermediate filaments through modulation of DARPP-32-dependent pathways in cerebral cortex of young rats.
2012-02
Spatiotemporal dynamics of excitation in rat insular cortex: intrinsic corticocortical circuit regulates caudal-rostro excitatory propagation from the insular to frontal cortex.
2010-01-13
GABAergic synapse properties may explain genetic variation in hippocampal network oscillations in mice.
2010
A Signal Processing Analysis of Purkinje Cells in vitro.
2010
Arcopallium, NMDA antagonists and ingestive behaviors in pigeons.
2009-12-07
Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of Parkinson's disease.
2009-06
Icilin-induced wet-dog shakes in rats are dependent on NMDA receptor activation and nitric oxide production.
2009-05
Efficient network reconstruction from dynamical cascades identifies small-world topology of neuronal avalanches.
2009-01
Are L-glutamate and ATP cotransmitters of the peripheral chemoreflex in the rat nucleus tractus solitarius?
2009-01
Prelimbic and infralimbic prefrontal cortex interact during fast network oscillations.
2008-07-16
Mesolimbic dopamine in desire and dread: enabling motivation to be generated by localized glutamate disruptions in nucleus accumbens.
2008-07-09
Glutamatergic contributions to nicotinic acetylcholine receptor agonist-evoked cholinergic transients in the prefrontal cortex.
2008-04-02
Role of the amygdaloid cholecystokinin (CCK)/gastrin-2 receptors and terminal networks in the modulation of anxiety in the rat. Effects of CCK-4 and CCK-8S on anxiety-like behaviour and [3H]GABA release.
2007-12
AMPA and NMDA receptor regulation of firing activity in 5-HT neurons of the dorsal and median raphe nuclei.
2007-05
Methotrexate induces seizure and decreases glutamate uptake in brain slices: prevention by ionotropic glutamate receptors antagonists and adenosine.
2006-12-03
NMDA receptor/L-VGCC-dependent expression and AMPA/KA receptor-dependent activation of c-Jun induced by cerebral ischemia in rat hippocampus.
2006-05-08
NMDA and group I metabotropic glutamate receptors activation modulates substance P release from the arcuate nucleus and median eminence.
2006-01-23
Activation of c-Jun NH2-terminal kinase 3 is mediated by the GluR6.PSD-95.MLK3 signaling module following cerebral ischemia in rat hippocampus.
2005-11-02
The putative glutamate receptor 1.1 (AtGLR1.1) in Arabidopsis thaliana regulates abscisic acid biosynthesis and signaling to control development and water loss.
2004-10
Activation of ERK5 is mediated by N-methyl-D-aspartate receptor and L-type voltage-gated calcium channel via Src involving oxidative stress after cerebral ischemia in rat hippocampus.
2004-02-26
NMDA receptor-mediated immediate Ser831 phosphorylation of GluR1 through CaMKIIalpha in rat hippocampus during early global ischemia.
2004-01
Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1.
2003-11
Antioxidant N-acetylcysteine and AMPA/KA receptor antagonist DNQX inhibited mixed lineage kinase-3 activation following cerebral ischemia in rat hippocampus.
2003-09
Contribution of ionotropic glutamate receptors to acute amphetamine-stimulated preproenkephalin mRNA expression in the rat striatum in vivo.
2003-07-31
Antioxidant NAC and AMPA/KA receptor antagonist DNQX inhibited JNK3 activation following global ischemia in rat hippocampus.
2003-06
Nuclear factor kappaB activation is mediated by NMDA and non-NMDA receptor and L-type voltage-gated Ca(2+) channel following severe global ischemia in rat hippocampus.
2002-04-12
Stereochemistry of quinoxaline antagonist binding to a glutamate receptor investigated by Fourier transform infrared spectroscopy.
2001-10-12
NADPH diaphorase activity in the rabbit retina is modulated by glutamatergic pathways.
2001-02-26
Optical recording of the spatiotemporal propagation of neuronal excitation in the rat hippocampal CA2-CA1 pathway.
2001
Patents

Patents

Sample Use Guides

Forty-eight adult Wistar-Kyoto (WKY) rats (an animal model for depressive behavior): DNQX (FG9041) (iv 2 mL 5 mg/kg DNQX through the tail veins of WKY rats )
Route of Administration: Intravenous
It was tested the effects of the quinoxaline derivative DNQX (FG9041) on the membrane potential of thalamic reticular nucleus (TRN) and ventrobasal (VB) neurons. DNQX (20 μM) produced a slow-onset, long-duration depolarization in all TRN neurons tested with average amplitude of 3.3 ± 1.1 mV. In contrast, DNQX (20 μM) did not alter the membrane potential (0.2 ± 0.5 mV, n = 6) or input resistance of VB neurons. Accordingly, in voltage-clamp recordings, DNQX (20 μM) evoked an inward current that averaged −14.3 ± 5.6 pA but not in VB neurons (1.3 ± 2.3 pA, n = 5, P > 0.1). At a lower concentration, DNQX (4 μM) produced a negligible depolarization (0.3 ± 0.3 mV, n = 5) in TRN neurons, but at higher concentrations, DNQX (100 μM) produced a larger depolarization that averaged 3.7 ± 1.6 mV.
Substance Class Chemical
Created
by admin
on Mon Mar 31 23:04:31 GMT 2025
Edited
by admin
on Mon Mar 31 23:04:31 GMT 2025
Record UNII
62T278S1MX
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FG-9041
Common Name English
DNQX
Preferred Name English
6,7-DINITROQUINOXALINE-2,3-DIONE
Systematic Name English
2,3-QUINOXALINEDIONE, 1,4-DIHYDRO-6,7-DINITRO-
Systematic Name English
Code System Code Type Description
PUBCHEM
3899541
Created by admin on Mon Mar 31 23:04:31 GMT 2025 , Edited by admin on Mon Mar 31 23:04:31 GMT 2025
PRIMARY
FDA UNII
62T278S1MX
Created by admin on Mon Mar 31 23:04:31 GMT 2025 , Edited by admin on Mon Mar 31 23:04:31 GMT 2025
PRIMARY
CAS
2379-57-9
Created by admin on Mon Mar 31 23:04:31 GMT 2025 , Edited by admin on Mon Mar 31 23:04:31 GMT 2025
PRIMARY
EPA CompTox
DTXSID60178476
Created by admin on Mon Mar 31 23:04:31 GMT 2025 , Edited by admin on Mon Mar 31 23:04:31 GMT 2025
PRIMARY
DRUG BANK
DB03759
Created by admin on Mon Mar 31 23:04:31 GMT 2025 , Edited by admin on Mon Mar 31 23:04:31 GMT 2025
PRIMARY
WIKIPEDIA
DNQX
Created by admin on Mon Mar 31 23:04:31 GMT 2025 , Edited by admin on Mon Mar 31 23:04:31 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY